CPHI vs KLAC · rev $4.1M vs P/E 55, rev $12.16B
China Pharma Holdings Inc (CPHI) versus KLA Corporation (KLAC) — a side-by-side from cached financials, not a winner call.
China Pharma Holdings Inc (CPHI) is a drug manufacturers - specialty & generic company listed on US.
KLA Corporation (KLAC) is a semiconductor equipment & materials company listed on US.
Latest reported CPHI revenue for 2025-12-31 was $4.1M. Net income was -$3.2M. Revenue was down 8.5% from 2024-12-31 to 2025-12-31. CPHI currently screens at market cap $29.0M.
Latest reported KLAC revenue for 2025-06-30 was $12.16B. Net income was $4.06B. KLAC currently screens at market cap $252.01B and trailing P/E 54.7.
CPHI currently screens at market cap $29.0M. KLAC currently screens at market cap $252.01B and trailing P/E 54.7.
Not investment advice. Open the CPHI and KLAC stock pages for the full models.
Not investment advice.